Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.2M Sell
371,350
-17,590
-5% -$1.74M 0.17% 116
2025
Q4
$43.5M Buy
388,940
+19,375
+5% +$2.27M 0.23% 88
2025
Q3
$46.8M Buy
369,565
+21,320
+6% +$2.96M 0.3% 69
2025
Q2
$50.7M Buy
348,245
+67,979
+24% +$10.2M 0.39% 51
2025
Q1
$42.4M Buy
280,266
+35,642
+15% +$5.24M 0.45% 49
2024
Q4
$34.2M Buy
244,624
+100,569
+70% +$14.3M 0.41% 53
2024
Q3
$19.4M Buy
144,055
+75,054
+109% +$9.53M 0.37% 61
2024
Q2
$8.19M Buy
69,001
+54,897
+389% +$6.71M 0.36% 66
2024
Q1
$1.74M Buy
14,104
+6,214
+79% +$754K 0.24% 85
2023
Q4
$924K Buy
+7,890
New +$935K 0.23% 102

Other funds holding PAYX

&Partners's PAYX Position: Q1 2026 in Review

&Partners reduced its Paychex (PAYX) stake by 4.5% in Q1 2026, selling an estimated $1.74M and leaving 371,350 shares worth $34.2M. The position accounts for 0.17% of the portfolio, ranked #116.

&Partners first reported a position in PAYX in Q4 2023 and has held it in 10 quarters since. The position peaked at $50.7M in Q2 2025. 1,503 funds tracked by Wall St. Rank hold PAYX as of Q1 2026.

  • &Partners held 371,350 shares of Paychex worth $34.2M as of Q1 2026.
  • &Partners sold 17,590 Paychex shares in Q1 2026, an estimated $1.74M.
  • Paychex made up 0.17% of &Partners's portfolio in Q1 2026, its #116 holding.
  • &Partners first reported a position in Paychex in Q4 2023 and has held it in 10 quarters since.
  • &Partners's Paychex position peaked at $50.7M in Q2 2025.
  • 1,503 funds tracked by Wall St. Rank held Paychex as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.